CIK 0001622229
- Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465308248
- Phone
- +1 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Fairmount Funds Management LLC Director | Conversion | +7,000,000 | 12,503,418 | ||
| 2026-03-31 | Fairmount Funds Management LLC Director | Sale | −7,000,000 | $34.66 | $242.6M | 5,503,418 |
| 2026-03-31 | Fairmount Funds Management LLC Director | Conversion · Series A Convertible Preferred Stock | −28,000 | 39,414 | ||
| 2026-01-22 | Fairmount Funds Management LLC Director | Sale | −3,500,000 | $36.40 | $127.4M | 5,503,418 |
| 2025-07-10 | Fairmount Funds Management LLC Director | Purchase | +2,777,777 | $9.00 | $25.0M | 9,003,418 |
| 2024-06-10 | Fairmount Funds Management LLC Director | Option exercise | +1,500,000 | 6,225,641 | ||
| 2024-06-10 | Fairmount Funds Management LLC Director | Option exercise · Series B Convertible Preferred Stock | −1,500 | 0 | ||
| 2024-03-28 | Fairmount Funds Management LLC Director | Other disposition | −286,851 | 0 | ||
| 2024-03-28 | Fairmount Funds Management LLC Director | Other acquisition | +286,851 | 4,725,641 | ||
| 2024-03-28 | Fairmount Funds Management LLC Director | Other disposition · Series A Convertible Preferred Stock | −11,914 | 0 | ||
| 2024-03-28 | Fairmount Funds Management LLC Director | Other acquisition · Series A Convertible Preferred Stock | +11,914 | 67,414 | ||
| 2024-02-16 | Fairmount Funds Management LLC 10% owner | Grant or award | +1,166,666 | $7.50 | $8.7M | 4,438,790 |
| 2024-02-16 | Fairmount Funds Management LLC 10% owner | Grant or award · Series B Convertible Preferred Stock | +1,500 | $7,500.00 | $11.3M | 1,500 |
| 2023-06-09 | Fairmount Funds Management LLC 10% owner | Purchase | +800,000 | $12.00 | $9.6M | 3,272,124 |
| 2022-06-16 | Fairmount Funds Management LLC 10% owner | Purchase | +1,200,000 | $8.25 | $9.9M | 2,472,124 |
| 2020-07-09 | Fairmount Funds Management LLC 10% owner | Purchase · Series A Convertible Preferred Stock | +3,692 | $880.00 | $3.2M | 11,914 |
| 2020-07-09 | Fairmount Funds Management LLC 10% owner | Purchase · Series A Convertible Preferred Stock | +19,035 | $880.00 | $16.8M | 55,500 |
| 2020-07-06 | Fairmount Funds Management LLC 10% owner | Other acquisition | +1,147,406 | 1,147,406 | ||
| 2020-07-06 | Fairmount Funds Management LLC 10% owner | Other acquisition | +5,088,497 | 5,088,497 | ||
| 2020-07-06 | Fairmount Funds Management LLC 10% owner | Other acquisition · Series A Convertible Preferred Stock | +8,222 | 8,222 |
Page 1 of 2 · 21 trades